Renhe Pharmaceutical: Announcement on the Company\'s wholly-owned subsidiary obtaining approval for supplementary drug applications

SZSI · Sep 25

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.